Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea
TAIPEI, Oct. 5, 2026 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657) today announced that it has signed a Memorandum of Understanding ("MOU") with Yoo Young Pharm. Co., Ltd. ("YYP"), a South Korea-based pharmaceutical company, to...
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
Development of Leptin receptor-based technology and hybrid LNP platform Combining Blood-Brain Barrier penetration and a one-month sustained-release formulation in a single structure, with potential applications in CNS-targeted therapeutics...
Xi Inspires | AI Development: A Symphony, Not a Solo
BEIJING, July 31, 2026 /PRNewswire/ -- A news report by chinadiplomacy.org.cn on Chinese President Xi Jinping's inspiring quotes on AI development and governance: Xi Inspires | AI Development: A Symphony, Not a Solo Will artificial intelligence...
Radisson Hotel Group appoints Armand Steinmeyer as Vice President, Development, Southeast Asia
BRUSSELS and SINGAPORE, June 1, 2026 /PRNewswire/ -- Radisson Hotel Group is pleased to announce the appointment of Armand Steinmeyer as Vice President, Development, Southeast Asia, further strengthening the Group's development leadership as it...
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 DAEJEON, South Korea, March 25, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that it has entered into an...
GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer
SEOUL, South Korea, March 20, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant...
MDJM LTD and H5 Advance Creative Development of International Animated Short Film
Intensive Script Workshops Highlight Artistic Depth and Cross-Cultural Creative Collaboration LONDON, March 16, 2026 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) ("MDJM" or the "Company") announced that the development of its animated short film project...
BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market
XI'AN, China, Feb. 19, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, today announced the successful...
Inheritance + Innovation + Development: The "Co-development" Path of Hakka Medicine and Traditional Chinese Medicine
HONG KONG, Dec. 9, 2025 /PRNewswire/ -- From November 23 to 25, the Seventh World Hakka Entrepreneurs Convention was held in Meizhou, Guangdong. The conference, with the theme of "Gather Global Hakka Entrepreneurs • Facilitate High-Quality...
Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development
Collaboration Aims to Expand Globally Connected Scientific Dialogue and Accelerate Innovation in Human Health and Sustainability SINGAPORE, May 7, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, the Yong Loo Lin School...